SPONSOR
China Immunotech (Beijing) Biotechnology Co., Ltd.
Total Trials
2
Recruiting
2
Phases
Phase 1
Conditions studied: Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Inflammatory MyopathyAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisAntiphospholipid Syndrome (APS)Rheumatoid Arthritis (RA)IgG4-Related DiseasesSjogren's SyndromeLupus Nephritis (LN)Sjogren's Syndrome (SS)
China Immunotech (Beijing) Biotechnology Co., Ltd. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Systemic Lupus Erythematosus (SLE), Systemic Sclerosis (SSc), Inflammatory Myopathy, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — China Immunotech (Beijing) Biotechnology Co., Ltd.
How many clinical trials has China Immunotech (Beijing) Biotechnology Co., Ltd. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by China Immunotech (Beijing) Biotechnology Co., Ltd., of which 2 are actively recruiting participants. These trials cover conditions including Systemic Lupus Erythematosus (SLE), Systemic Sclerosis (SSc), Inflammatory Myopathy. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does China Immunotech (Beijing) Biotechnology Co., Ltd. research focus on?
China Immunotech (Beijing) Biotechnology Co., Ltd. clinical trials span Systemic Lupus Erythematosus (SLE), Systemic Sclerosis (SSc), Inflammatory Myopathy, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antiphospholipid Syndrome (APS), and additional conditions. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a China Immunotech (Beijing) Biotechnology Co., Ltd. clinical trial?
To participate in a China Immunotech (Beijing) Biotechnology Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all China Immunotech (Beijing) Biotechnology Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by China Immunotech (Beijing) Biotechnology Co., Ltd.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology